Xuanwu hospital of capital medical university
Welcome,         Profile    Billing    Logout  
 115 Trials 
202 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chan, Piu
NCT06147713: Vibrotactile Foot Device for Freezing of Gait in Parkinson's Disease

Recruiting
N/A
200
RoW
Vibrotactile foot device (Smart shoe)
Xuanwu Hospital, Beijing
Parkinson Disease, Freezing of Gait
11/24
11/24
Zhang, Yan
NCT05291650: Ultrasound-guided Injection of Glucocorticoid Into Infrapatellar Fat Pad in Patients With Knee Osteoarthritis

Completed
4
60
RoW
Glucocorticoids, Saline, Hyaluronic acid
Zhujiang Hospital
Osteoarthritis, Knee
09/23
12/23
NCT04790305: Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Recruiting
4
1072
RoW
Huaier Granule, Z20000109(NMPA Approval Number)
Fudan University, LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Carcinoma Breast, Triple-negative Breast Cancer, Invasive Ductal Carcinoma, Breast
12/27
07/28
ETER701, NCT04234607: A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer

Not yet recruiting
3
738
RoW
TQB2450, Anlotinib, Etoposide, Carboplatin, TQB2450(blank), Anlotinib(blank)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Extensive Small Cell Lung Cancer
12/22
12/22
KRYSTAL-12, NCT04685135 / 2020-003645-11: Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

Hourglass Jan 2023 - Jun 2023 : Completion of enrollment of KRYSTAL-12 trial for 2L NSCLC
Active, not recruiting
3
453
Europe, US, RoW
MRTX849, adagrasib, KRAZATI, Docetaxel, Taxotere
Mirati Therapeutics Inc., Mirati Therapeutics, Inc.
Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer
12/23
12/24
NCT05181137 / 2021-001940-86: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

Recruiting
3
368
Europe, US, RoW
SHR0302, Placebo
Reistone Biopharma Company Limited, Reistone Biopharma Company Limited
Ulcerative Colitis
10/24
03/25
SUNRAY-01, NCT06119581: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Recruiting
3
1016
Europe, Canada, Japan, US, RoW
LY3537982, Olomorasib, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed
Eli Lilly and Company, Loxo Oncology, Inc.
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
10/26
10/29
NCT02159820: Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer

Recruiting
2/3
500
RoW
Decitabine (DTC Arm), Paclitaxel and Carboplatin (TC Arm)
Chinese PLA General Hospital
Primary Malignant Neoplasm of Ovary, FIGO Stages II to IV
06/24
06/24
EVEREST, NCT06531161: EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill

Not yet recruiting
2/3
168
NA
Suxiao Jiuxin Pill, Placebo
Peking University First Hospital, Tibet Autonomous Region Hospital of Traditional Tibetan Medicine
Acute Mountain Sickness
09/24
09/25
NCT03989336: A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

Completed
2
84
RoW
Manganese Chloride, nab-paclitaxel, Paclitaxel For Injection (Albumin Bound), Platinum chemotherapy, Sintilimab, anti-PD-1 antibody; PD-1 inhibitor
Chinese PLA General Hospital
Ovarian Cancer
05/22
12/23
NCT03250962: SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

Recruiting
2
280
RoW
SHR-1210, Decitabine
Chinese PLA General Hospital
Hodgkin Lymphoma
07/22
03/25
LEAD, NCT05092412: Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Active, not recruiting
2
30
RoW
Low-dose radiotherapy, Durvalumab, Etoposide, and cisplatin/carboplatin
You Lu, AstraZeneca
Lung Cancer, Extensive-stage Small-cell Lung Cancer, Durvalumab
02/23
06/25
2022-PUMCH-A-194, NCT06176729: Pola-R2 in Newly Diagnosed Non-fit Elderly DLBCL Patients

Recruiting
2
30
RoW
Polatuzumab Vedotin, Rituximab, Lenalidomide
Yan Zhang, MD, Peking University Third Hospital, Peking University First Hospital, Chinese PLA General Hospital
Diffuse Large B Cell Lymphoma
10/25
10/27
PUMCH-NHL-013, NCT05390749: Sequential Treatment With RO-MTX After Pomalidomide, Orelabrutinib, Rituximab (POR) in Newly-diagnosed PCNSL

Recruiting
2
50
RoW
Orelabrutinib, Pomalidomide, Rituximab, Methotrexate
Peking Union Medical College Hospital, Beijing Tiantan Hospital, Sanbo Brain Hospital Capital Medical University
Primary Central Nervous System Lymphoma
04/24
04/26
NCT06632262: A Phase 2 Clinical Study of ABSK061 and ABSK043

Not yet recruiting
2
202
RoW
ABSK061 + ABSK043, ABSK061+ABSK043 in combination with CAPOX
Abbisko Therapeutics Co, Ltd
HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Solid Tumors
11/29
06/30
FOCUS-C, NCT05334277: Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

Recruiting
2
280
RoW
Furmonertinib, AST2818, Furmonertinib/Pemetrexed/Carboplatin, Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab
Sun Yat-sen University, Allist Pharmaceuticals, Inc., GeneCast Biotechnology Co., Ltd.
Non-small Cell Lung Cancer
02/25
02/28
IMM01-04, NCT05833984: Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas

Recruiting
1b/2
309
RoW
IMM01, SIRPα Fc, Tislelizumab
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Solid Tumor, Classic Hodgkin Lymphoma
02/24
11/24
NCT03989310: An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Recruiting
1/2
50
RoW
Manganese Chloride, nab-paclitaxel, Paclitaxel For Injection (Albumin Bound), Gemcitabine, anti-PD-1 antibody, Anti-PD-1 monoclonal antibody; PD-1 inhibitor
Chinese PLA General Hospital
Pancreatic Cancer
05/21
03/22
NCT04588324: Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors

Recruiting
1/2
50
RoW
SHR2150, Anti-Cancer Agent
Chinese PLA General Hospital
Solid Tumor
11/21
11/22
NCT04873440: An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma

Recruiting
1/2
10
RoW
Manganese Chloride, Mn2+, Radiotherapy, Chemo-immunotherapy
Chinese PLA General Hospital
Solid Tumor, Lymphoma
05/22
05/23
REMLA, NCT04120350: R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL:a Multicenter Phase Ib/II Stuty

Recruiting
1/2
47
RoW
Methotrexate, Rituximab, Lenalidomide
Peking Union Medical College Hospital, Beijing Tiantan Hospital, Xuanwu Hospital, Beijing, Peking University Third Hospital, Beijing Hospital, Peking University First Hospital, Chinese PLA General Hospital
Primary Central Nervous System Lymphoma
08/22
08/24
NCT05867771: A Study of PM1022 in Patients With Advanced Tumors

Recruiting
1/2
200
RoW
PM1022
Biotheus Inc.
Advanced Tumors
04/24
04/25
NCT05416775: Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Recruiting
1/2
168
RoW
SHR-8068;Adebrelimab, SHR-8068;adebrelimab and platinum-based chemotherapy, Adebrelimab;platinum-based chemotherapy
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Advanced Non-small Cell Lung Cancer
06/26
06/26
NCT05245916: IBI397 or Combination Therapies in Patients With Advanced Malignancies

Withdrawn
1a/1b
30
RoW
IBI397, IBI397+Sintilimab, IBI397+Rituximab
Innovent Biologics (Suzhou) Co. Ltd.
Advanced Malignancies
08/23
08/23
NCT06271928: A Multicenter Clinical Study of Yijing Keli in the Treatment of Ovarian Aging

Recruiting
1
100
RoW
Yijing Keli
Tongji Hospital
Ovarian Aging
01/24
01/25
NCT04487093: Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer

Recruiting
1
20
RoW
neoantigen vaccine + EGFR-TKI, neoantigen vaccine + anti-angioge
First Hospital of Shijiazhuang City, Tianjin Hengjia Biotechnology Development co., LTD
Non Small Cell Lung Cancer
05/22
12/22
NCT06256783: A Clinical Study of Baozhu Keli in the Treatment of Ovarian Aging

Recruiting
1
100
RoW
Baozhu Keli
Tongji Hospital
Ovarian Aging
01/24
01/25
SHR-A2009-I-101, NCT05114759: A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors

Recruiting
1
132
Japan, RoW
SHR-A2009
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Advanced Solid Tumors
12/23
12/24
NCT05508334: A Study to Assess the Safety and Tolerability of RC88 for Patients with Advanced Solid Tumours

Active, not recruiting
1
81
RoW
RC88, The injectable RC88
RemeGen Co., Ltd.
Advanced Solid Tumours
06/25
12/25
CS5001-101, NCT05279300: A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas

Hourglass Sep 2024 - Sep 2024 : Data for adv solid tumors
Recruiting
1
156
US, RoW
CS5001
CStone Pharmaceuticals
Advanced Solid Tumor, Advanced Lymphoma
03/25
06/25
NCT06384352: A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

Recruiting
1
155
Canada, US, RoW
YL211
MediLink Therapeutics (Suzhou) Co., Ltd., Hoffmann-La Roche
Advanced Solid Tumors
04/27
04/29
PE, NCT03542279: Early for Autoimmune Encephalitis

Completed
N/A
70
RoW
Plasma exchange (PE), intravenous immunmoglobulin (IVIG), intravenous methylprednisolone (IVMP)
Xuanwu Hospital, Beijing
Autoimmune Encephalitis
12/22
09/24
NCT03703284: Molecular Mechanisms of Malignant Cerebral Edema After LHI

Recruiting
N/A
120
RoW
Treatments to reduce intracranial pressure
Xuanwu Hospital, Beijing
Cerebral Edema
12/22
06/23
UltraFuture I, NCT05498740: Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia

Recruiting
N/A
200
RoW
Drug eluting Balloon
Zhejiang Zylox Medical Device Co., Ltd.
Peripheral Arterial Disease (PAD)
12/22
12/24
NCT05447572: FIT Combining FC for Predicting MH and Histology Remission in UC

Recruiting
N/A
300
RoW
FIT + FC
Shandong University
Ulcerative Colitis, Histology Remission, Fecal Calprotetin, FIT, Mucosal Healing
12/22
12/23
NCT04361357: The Effects of Enteral Whey Protein Supplement on Serum Albumin Level in Acute Critically Ill Neurological Patients

Recruiting
N/A
116
RoW
whey protein
Xuanwu Hospital, Beijing
Nutrition Disorders, Neurologic Disorder
12/22
12/22
NCT05840861: Using 18F-FPEB PET to Identify mGLUR5 Availability in Affective Disorders

Recruiting
N/A
59
RoW
Vortioxetine, Quetiapine
Central South University
Major Depressive Disorder, Bipolar Disorder
08/23
09/23
DELTA, NCT05608655: DKutting Balloon Versus Chocolate Balloon to Treat Femoral and Popliteal Artery Stenosis

Completed
N/A
188
RoW
DKutting LL balloon, Chocolate balloon
DK Medical Technology (Suzhou) Co., Ltd.
Femoral Artery Stenosis, Popliteal Artery Stenosis
01/24
02/24
BIATICH, NCT05593380: The Effect of BIA Monitoring of Brain Edema on the Neurological Prognosis of Supratentorial Massive ICH

Recruiting
N/A
190
RoW
Parenchymal Intracranial pressure monitor, Integra Life Sciences Camino Intracranial Monitor, Treatment based on clinical and imaging observations
Xiangya Hospital of Central South University
Cerebral Hemorrhage, Hypertensive, Intracranial Hypertension, Monitoring, Critical Care, Treatment Outcome, Invasive Intracranial Pressure Monitoring, Large-volume Cerebral Hemorrhage
12/24
03/25
NCT06130319: Correlation of Disease Management and Quality of Life in Patients With Chronic Heart Failure and Their Family Caregivers

Recruiting
N/A
278
RoW
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Chronic Heart Failure
06/24
06/24
EVL, NCT06250803: Early Pancreatic Stent Placement for Preventing PEP

Not yet recruiting
N/A
768
RoW
early pancreatic stent placement (EPSP), late pancreatic stent placement (EPSP)
The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital Bengbu Medical College, Anqing Municipal Hospital, First Affiliated Hospital of Wannan Medical College, Tongcheng People's Hospital of Anhui province, Fuyang people's hospital
Cholangiopancreatography, Endoscopic Rretrograde, Post-ERCP Pancreatitis
03/26
03/26
NCT06452173: Risk Prediction Model for Cerebrovascular Events in Carotid Artery Stenosis

Enrolling by invitation
N/A
300
RoW
Plasma, carotid high-resolution magnetic resonance imaging
Beijing Tiantan Hospital, Beijing Neurosurgical Institute
Carotid Stenosis
10/26
12/26
NCT06606509: The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).

Not yet recruiting
N/A
1000
RoW
Continuous Glucose Monitoring System (GX-01S)
Nanjing First Hospital, Nanjing Medical University
Type1 Diabetes Mellitus
10/26
06/27
NCT05454397: A Study on the Status of Nutritional Risk Screening and Nutritional Therapy in Neurology Hospitalized Stroke Patients

Recruiting
N/A
2000
RoW
Observational study, no intervention
Nanfang Hospital of Southern Medical University, First Affiliated Hospital of Fujian Medical University, Yantai Yuhuangding Hospital, The First Hospital of Jilin University, Qilu Hospital of Shandong University, ZHEJIANG PROVINCE XIAOSHAN HOSPITAL, The First People's Hospital of Wenling, Ganzhou People's Hospital, Affiliated Hospital of Jining Medical hospital, Henan Provincial People's Hospital, Zhongda Hospital Southeast University, The Second Affiliated Hospital of Harbin Medical University, The First people's Hospital of Kunshan, The 2nd Affiliated Hospital of Wenzhou Medical University, THE FIRST PEOPLE'S HOSPITAL OF JIASHAN, The First Affiliated Hospital of Xi'an Jiaotong University Medical College, Fujian Province Zhangzhou Hospital, People's Hospital of Chongqing, Nanjing Zijin Hospital, Hangzhou Red Cross Hospital, Wenzhou Hospital of Chinese Medicine, Kaifeng Central Hospital, First Affiliated Hospital of Guangxi Medical University, Zhongshan Hospital of Xiamen University, Xi'an Encephalopathy of Traditional Chinese Medicine Hospital, 903 Hospital of the Chinese People's Liberation Army Joint Logistics and Security Forces, Xiangya Hospital of Central South University, Second Affiliated Hospital of Suzhou University, Tongji Hospital, The Affiliated Hospital o fQingdao University, The First Affiliated Hospital of Anhui Medical University, Yancheng Third People's Hospital, Linyi People's Hospital, Dongfang Hospital of Beijing University of Chinese Medicine, Affiliated Hospital of Qingdao University
Acute Stroke
10/22
10/23
Ji, Xunming
NCT05965687: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

Recruiting
3
1230
RoW
Normobaric Hyperoxia, Nasal oxygen, Intravenous thrombolysis(rt-PA)
Ji Xunming,MD,PhD, Beijing Friendship Hospital, Beijing Shijitan Hospital, Capital Medical University, Beijing Tongren Hospital, People's Hospital of Beijing Daxing District, Tianjin Huanhu Hospital, Guizhou Provincial People's Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Soochow University, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Jining First People's Hospital, Linyi People's Hospital, Nanyang Central Hospital, Rizhao People's Hospital, Zhumadian Central Hospital, Second Affiliated Hospital of Nanchang University, Affiliated Hospital of Nantong University, The Second Hospital of Anhui Medical University, Changsha Central Hospital, Jiujiang University Affiliated Hospital, Liaocheng People's Hospital, Chengde Central Hospital, The First Affiliated Hospital of Anhui Medical University, Jiangxi Provincial People's Hopital
Acute Ischemic Stroke
08/24
10/24
RECAST-MT, NCT06559241: Remote Ischemic Conditioning for Acute Ischemic Stroke Treated with Mechanical Thrombectomy()

Recruiting
3
2105
RoW
14-day remote ischemic conditioning, 14-day RIC, 30-day remote ischemic conditioning, 30-day RIC, Endovascular thrombectomy, EVT, Best medical management
Capital Medical University
Acute Ischemic Stroke, Anterior Circulation Brain Infarction
11/26
02/27
NCT05965193: Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke:Longterm Outcome (OPENS-3L)

Recruiting
3
1230
RoW
Normobaric Hyperoxia, Nasal oxygen, Intravenous thrombolysis(rt-PA)
Ji Xunming,MD,PhD, Beijing Friendship Hospital, Beijing Shijitan Hospital, Capital Medical University, Beijing Tongren Hospital, People's Hospital of Beijing Daxing District, Tianjin Huanhu Hospital, Guizhou Provincial People's Hospital, Shandong Provincial Hospital, The First Affiliated Hospital of Soochow University, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Jining First People's Hospital, Linyi People's Hospital, Nanyang Central Hospital, Rizhao People's Hospital, Zhumadian Central Hospital, Second Affiliated Hospital of Nanchang University, Affiliated Hospital of Nantong University, The Second Hospital of Anhui Medical University, Changsha Central Hospital
Acute Ischemic Stroke
08/25
10/25
STATIC, NCT04857632: Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage

Recruiting
2/3
98
RoW
Statin
Capital Medical University
Intracerebral Hemorrhage, Statins
06/24
11/24
IRIS, NCT06238024: Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

Completed
2/3
108
RoW
Tocilizumab, NaCl 0.9% 100ml
Suzhou Municipal Hospital of Anhui Province, Xuanwu Hospital, Beijing
Interleukin-6, Ischemic Stroke, Endovascular Treatment
06/24
09/24
NO SUSPENSION, NCT05351073: The Prehospital Administration of Normobaric Oxygen in Suspected Stroke

Recruiting
2
100
RoW
NBO
Capital Medical University
Acute Stroke, Ischemic Stroke, Acute
07/22
10/22
OPENS-2, NCT04681651: Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke

Completed
2
282
RoW
Normobaric Hyperoxia, NBO, Sham Normobaric Hyperoxia, Sham NBO, Endovascular Thrombectomy, EVT
Capital Medical University, Tianjin Huanhu Hospital, Shengli Oilfield Hospital, Beijing Fengtai You'anmen Hospital, Jiujiang University Affiliated Hospital, Zhangzhou Municipal Hospital of Fujian Province, Baotou Central Hospital, Luoyang Central Hospital, Nanyang Central Hospital, Qingdao Central Hospital, The Third People's Hospital of Jinan, Rizhao People's Hospital, Anyang People's Hospital, Shanghai 10th People's Hospital, Dalian Municipal Central Hospital, Zhoukou Central Hospital, Nanshi Hospital of Nanyang, The second Nanning People's Hospital, Zhumadian Central Hospital, Taizhou Hospital, Second Affiliated Hospital of Nanchang University
Stroke, Acute, Neuroprotection
05/23
05/23
CHILL-1, NCT06663631: Study on Hibernation-like Therapy Based on Mechanical Thrombectomy

Recruiting
1
32
RoW
chlorpromazine and promethazine, C+P, lytic cocktail, Placebo group, Control group, endovascular thrombectomy, rt-PA, Intravenous thrombolysis
Capital Medical University, Linyi People's Hospital
Acute Ischemic Stroke
01/25
02/25
RE-HIBER, NCT04554797: Regional Hypothermia in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke

Recruiting
N/A
60
RoW
Regional Hypothermia
Capital Medical University
Stroke, Neuroprotection, Hypothermia
12/20
03/21
RIC-PMD, NCT03546309: Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy

Recruiting
N/A
42
RoW
RIC group, Medication group
Capital Medical University, The Fifth Medical Center of the Chinese People's Liberation Army (PLA) General Hospital
Moyamoya Disease, Pediatric
12/24
02/25
RIC-BPG, NCT04192578: Effect of RIC on 2,3-BPG in Erythrocyte

Not yet recruiting
N/A
40
NA
remote ischemic conditioning
Capital Medical University
2,3-Bisphosphoglycerate
03/21
03/21
NCT02737189: Basilar Artery Occlusion Chinese Endovascular Trial

Completed
N/A
217
RoW
Mechanical embolectomy, Medical Treatment
Xuanwu Hospital, Beijing, Zhangzhou Municipal Hospital of Fujian Province, The First People's Hospital of Changzhou, Xinqiao Hospital of Chongqing, Changhai Hospital, Baotou Central Hospital, The 904 Hospital of PLA, Linyi People's Hospital, The 985 Hospital of PLA, Taiyuan, Shanxi, The First Affiliated Hospital with Nanjing Medical University, Tianjin TEDA Hospital, Liaocheng People's Hospital, Luoyang Central Hospital, Subei People's Hospital of Jiangsu Province, PLA 148 Hospital, Zibo, Shandong, Hebei General Hospital, Shengli Oilfield Hospital, Shenzhen Bao'an District People's Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Peking University Binhai Hospital, Beijing Tiantan Hospital, The Military General Hospital of Beijing, PLA, The First Affiliated Hospital of Shanxi Medical University, Beijing Luhe Hospital, Affiliated Hospital of Nantong University, The Affiliated Hospital Of Guizhou Medical University, Nanning Second People's Hospital, Chongqing Three Gorges Central Hospital, The First Affiliated Hospital of Dalian Medical University, The Fifth Central Hospital of Tianjin,TianJin, Yantaishan Hospital, Nanyang Central Hospital, Second Affiliated Hospital of Soochow University, Tianjin Huanhu Hospital, The Affiliated Hospital of Northwest University, Xi'an NO.3 Hospital
Basilar Artery Occlusion, Ischemic Stroke, Cerebrovascular Disorders
09/21
06/22
RIC-SVD, NCT04816500: Remote Ischemic Conditioning on Cerebral Small Vessel Disease

Recruiting
N/A
60
RoW
Automatic ischemic conditioning treatment instrument, Regular treatment
Capital Medical University
Cerebral Small Vessel Diseases
12/21
12/21
NCT05207475: Safety and Efficacy of Remote Ischemic Conditioning on Cerebral Amyloid Angiopathy. (RIC-CAA)

Recruiting
N/A
30
RoW
Remote ischemic conditioning
Capital Medical University
Cerebral Amyloid Angiopathy
01/22
01/22
RIC-CAAH, NCT04757597: Remote Ischemic Conditioning for Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage

Recruiting
N/A
30
RoW
Remote ischemic conditioning
Capital Medical University, Wangjing Hospital, China Academy of Chinese Medical Sciences, Bejing Fengtai You'anmen Hospital
Intracerebral Hemorrhage Lobar, Cerebral Amyloid Angiopathy
03/22
06/22
NCT04470492: Study on Prevention and Treatment of Atherosclerotic Cerebral Occlusive Disease With Remote Ischemic Conditioning

Not yet recruiting
N/A
700
NA
Doctormate®+Medical Management, Medical Management
Ji Xunming,MD,PhD
Cerebral Atherosclerosis
08/22
12/22
NCT05291585: The Dedicated Venous Sinus Thrombectomy Stent for Endovascular Treatment of Cerebral Venous Sinus Thrombosis.

Completed
N/A
60
RoW
the dedicated venous sinus thrombectomy stent, balloon catheter thrombectomy
Ji Xunming,MD,PhD
Cerebral Venous Sinus Thrombosis
03/23
07/23
NCT05263531: Remote Ischemic Conditioning for Motor Recovery After Acute Ischemic Stroke

Recruiting
N/A
20
RoW
remote ischemic conditioning
Ji Xunming,MD,PhD
Ischemic Stroke
12/22
01/23
NCT05426707: Remote Ischemic Conditioning for the Treatment of Resistant Hypertension

Not yet recruiting
N/A
40
NA
RIC, Sham-RIC
Ji Xunming,MD,PhD
Resistant Hypertension
02/23
03/23
BBBD-AIS, NCT05321225: The Level of Blood Brain Barrier Damage Biomarker in Acute Ischemic Stroke

Recruiting
N/A
1000
RoW
the level of biomarker in bood
Ji Xunming,MD,PhD
Ischemic Stroke
03/23
12/25
NCT05448248: Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)

Completed
N/A
3276
RoW
Capital Medical University, Brain Hospital of Hunan Provincial, The First Affiliated Hospital of Zhengzhou University, The Affiliated Hospital of Xuzhou Medical University, Guizhou Provincial People's Hospital
Cerebral Vein Thrombosis, Cerebral Venous Sinus Thrombosis
12/23
12/23
NCT05342714: Remote Ischemic Conditioning for Chronic Cerebral Artery Occlusion

Recruiting
N/A
30
RoW
Remote ischemic conditioning
Capital Medical University
Cerebral Artery Occlusion
03/23
03/23
NCT05733338: The Effects of Intermittent Hypoxia on Acute Hypoxic Injury

Recruiting
N/A
100
RoW
Intermittent Hypoxia, Sham Intermittent Hypoxia
Capital Medical University
Acute Mountain Sickness
04/23
04/23
NCT05760950: A Cohort Study of Patients With Intracranial Hemorrhage

Recruiting
N/A
300
RoW
Routine clinical treatment
Capital Medical University
Intracerebral Hemorrhage
05/23
06/23
NCT05413837: Anatomical Variation of Cerebral Venous Sinus in Healthy Individuals

Recruiting
N/A
40
RoW
anotomy and variation of venous sinus, the level of biomarker in bood
Capital Medical University
Venous Sinus Thrombosis, Cranial
08/23
08/23
NCT05128422: Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke

Completed
N/A
120
RoW
Normobaric oxygen therapy
Capital Medical University
Stroke, Endovascular Treatment, Neuroprotection
10/23
10/23
RIC-SI, NCT05289518: Remote Ischemic Conditioning for the Treatment of Stroke-related Insomnia

Not yet recruiting
N/A
136
RoW
Remote ischemic conditioning (RIC), Sham remote ischemic conditioning (Sham-RIC)
Ji Xunming,MD,PhD
Acute Ischemic Stroke
12/23
12/23
NCT05820165: Brain Imaging in Cerebral Venous Outflow Disturbance

Recruiting
N/A
80
RoW
high-resolution 3D-T1, diffusion tensor imaging (DTI), resting-state functional magnetic resonance imaging (rs-fMRI), arterial spin labeling (ASL) perfusion magnetic resonance imaging (MRI), susceptibility-weighted images (SWIs)
Capital Medical University
Abnormal Cerebral Venous Sinus Morphology, Internal Jugular Vein Stenosis, Image
12/23
12/24
NCT06584318: Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer

Recruiting
N/A
20
RoW
Intermittent hypoxia intervention
Capital Medical University
Colorectal Cancer
03/25
04/25
NBOL, NCT05039697: Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset:Longterm Outcome

Recruiting
N/A
280
RoW
oxygen
Capital Medical University
Stroke, Acute, Hypoxia-Ischemia, Brain, ENDOVASCULAR TREATMENT
04/24
04/24
BAOCHE2, NCT06560203: Basilar Artery Occlusion Chinese Endovascular Trial in the Extended Time Window

Recruiting
N/A
309
RoW
Mechanical thrombectomy
Capital Medical University
Acute Ischemic Stroke, Basilar Artery Occlusion
06/26
06/26
NCT05781880: Normobaric Hyperoxia Stabilizing Ischemic Penumbra

Recruiting
N/A
78
RoW
Oxygen 100%, Normobaric hyperoxia
Ji Xunming,MD,PhD
Acute Ischemic Stroke
11/24
12/24
MIRACLE-S, NCT06688162: Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage--Small Hemorrhage Evacuation

Not yet recruiting
N/A
750
NA
Usual Care, Minimally Invasive Soft Channel Brain Haemorrhage Evacuation (scMIS)
Capital Medical University, Fudan University, Linyi People's Hospital
Intracerebral Hemorrhage
11/26
12/26
MIRACLE-L, NCT06688201: Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage-- Large Hemorrhage Evacuation

Recruiting
N/A
550
RoW
Other neurosurgical techniques, Minimally Invasive Soft Channel Brain Haemorrhage Evacuation
Capital Medical University, Linyi People's Hospital, Fudan University
Intracerebral Hemorrhage
11/26
12/26
RICA-2, NCT05982015: Efficacy Study II on Remote Ischemic Conditioning for the Prevention of Stroke-Associated Pneumonia

Completed
N/A
1651
RoW
Remote ischemic conditioning, Sham remote ischemic conditioning
Capital Medical University
Stroke
09/24
12/24
CCC, NCT03919305: Cerebral Venous Thrombosis Cohort Study in China Mainland

Not yet recruiting
N/A
3000
NA
Capital Medical University, Beijing Municipal Science & Technology Commission
Cerebral Venous Sinus Thrombosis, Deep Cerebral Vein Thrombosis, Cortical Vein Thrombosis
05/28
05/29
RVS-ICAS, NCT05270746: The Predictive Value of Retinal Vascular Signs for Intracranial Artery Stenosis

Not yet recruiting
N/A
1000
RoW
Capital Medical University
Intracranial Stenosis
06/22
07/22
AIS-EVT, NCT05213754: Acute Ischemic Stroke Registry for Endovascular Treatment

Recruiting
N/A
500
RoW
Endovascular Treatment
Capital Medical University
Acute Ischemic Stroke
12/22
06/23
Jia, Jianping
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

Recruiting
4
1312
RoW
GV-971, Placebo
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer's Disease
06/29
12/29
NCT03789760: The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule

Completed
3
493
RoW
SaiLuoTong capsule, The effects of SaiLuoTong capsule on VaD, placebo
Shineway Pharmaceutical Co.,Ltd
Vascular Dementia
03/24
05/24
NCT03804229: Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia

Active, not recruiting
3
707
RoW
Butylphthalide soft capsule, The effects of Butylphthalide soft capsule on VaD, Placebo soft capsule, Placebo
Capital Medical University, CSPC-NBP Pharmaceutical Co., Ltd.
Vascular Dementia
10/24
02/25
TRAILBLAZER-ALZ 5, NCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

Recruiting
3
1500
Europe, RoW
Donanemab, (LY3002813), Placebo
Eli Lilly and Company
Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders
04/27
04/27
NCT05811442: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Recruiting
2a
60
RoW
50561 high dose, 50561 low dose, Placebo
Beijing Joekai Biotechnology LLC
Alzheimer's Disease
05/24
06/24
NCT05269173: Efficacy and Safety of Flos Gossypii Flavonoids Tablet in the Treatment of Alzheimer's Disease

Completed
2
240
RoW
Flos gossypii flavonoids tablet
Capital Medical University, Xinjiang Uygur Pharmaceutical Co., Ltd.
Alzheimer Disease
08/24
11/24
NCT05670912: Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease

Terminated
2
105
RoW
Wei Li Bai capsules, Placebo Comparator of Wei Li Bai capsules
Capital Medical University, China-Japan Friendship Hospital, Beijing Friendship Hospital
Alzheimer Disease
11/24
11/24
NCT04850053: Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis

Recruiting
N/A
1500
RoW
Capital Medical University, Shandong Provincial Hospital, Xiangya Hospital of Central South University, Zhejiang Provincial People's Hospital, Beijing Geriatric Hospital, Kaifeng Central Hospital, The First Affiliated Hospital of Chongqing Medical Universty, Huashan Hospital, First Affiliated Hospital Xi'an Jiaotong University, West China Hospital, Henan Provincial People's Hospital
Alzheimer's Disease
12/24
12/24
JT821, NCT06681948: The Ketogenic Diet in the Treatment of Alzheimer's Disease

Recruiting
N/A
300
RoW
Ketogenic diet, placebo
Capital Medical University, West China Hospital, The First Affiliated Hospital of Zhengzhou University, Tianjin Huanhu Hospital, Shandong Provincial Hospital, Peking University Third Hospital, Shanghai Mental Health Center, Beijing Tiantan Hospital, Xiangya Hospital of Central South University, First Affiliated Hospital of Chongqing Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Sichuan Provincial People's Hospital, Brain Hospital Affiliated to Guangzhou Medical University, Sir Run Run Shaw Hospital, Zhejiang University
Alzheimer Disease
05/25
05/25
NCT04575337: Study on Biomarkers for Early Diagnosis of Alzheimer's Disease

Recruiting
N/A
6000
RoW
Capital Medical University
Alzheimer Disease
06/25
06/25
NCT05020106: The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease

Recruiting
N/A
3200
RoW
Capital Medical University, Shandong Provincial Hospital, Second Affiliated Hospital, School of Medicine, Zhejiang University, Xiangya Hospital of Central South University, Huashan Hospital, The First Hospital of Jilin University
Alzheimer's Disease
09/25
09/25
COAST, NCT03653156: China Cognition and Aging Study

Recruiting
N/A
100000
RoW
Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Hunan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, Wuhan University Zhongnan Hospital, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital
Mild Cognitive Impairment(MCI), Alzheimer Disease, Late Onset, Familial Alzheimer Disease (FAD), Vascular Dementia (VaD), Normal Control, Non-Alzheimer Degenerative Dementia
01/38
01/38
CFAN, NCT03657732: The Chinese Familial Alzheimer's Network

Recruiting
N/A
40000
RoW
Capital Medical University, Beijing Tiantan Hospital, Beijing Chao Yang Hospital, Fu Xing Hospital, Capital Medical University, Peking Union Medical College Hospital, Peking University First Hospital, Peking University Third Hospital, Chinese PLA General Hospital, China-Japan Friendship Hospital, Beijing Geriatric Hospital, The First Affiliated Hospital of Dalian Medical University, Fujian Medical University Union Hospital, Guangzhou Psychiatric Hospital, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Handan Central Hospital, Hebei General Hospital, First Hospital of Shijiazhuang City, Tangshan Worker's Hospital, Henan Provincial People's Hospital, Kaifeng Central Hospital, People's Hospital of Zhengzhou University, First Affiliated Hospital of Harbin Medical University, Tongji Hospital, People's Hospital Affiliated Hubei Medical University, Wuhan University Zhongnan Hospital, The Third Xiangya Hospital of Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, Subei People's Hospital of Jiangsu, Nantong University Affiliated Hospital, Mineral General Hospital, Xuzhou, Jiangxi Provincial People's Hopital, Anshan Central Hospital, The Affiliated Zhongshan Hospital of Dalian University, First Hospital of China Medical University, Baotou Central Hospital, General Hospital of Ningxia Medical University, The People's Hospital of Ningxia, The Affiliated Hospital of Qingdao University, The 960th Hospital of PLA, Qilu Hospital of Shandong University, Qilu Hospital of Shandong University (Qingdao), Shandong Provincial Hospital, Qingdao Municipal Hospital, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, RenJi Hospital, Shanghai Changzheng Hospital, Affiliated Hospital of North Sichuan Medical College, Tianjin Huanhu Hospital, Tianjin Medical University General Hospital, Traditional Chinese Medicine Hospital of Xinjiang Autonomous Region, Ningbo Medical Center Lihuili Hospital, First Affiliated Hospital of Wenzhou Medical University, First Affiliated Hospital of Zhejiang University, Shao Yifu Hospital of Zhejiang Medical University, Zhejiang Provincial People's Hospital, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, The Second Affiliated Hospital of Chongqing Medical University, The First Affiliated Hospital of Anhui Medical University, People's Hospital of Chongqing, Dongfang Hospital Beijing University of Chinese Medicine, Zigong No.1 Peoples Hospital
Alzheimer Disease, Familial Alzheimer Disease (FAD)
01/38
01/38
Zhang, Yi
NCT04771689: Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients

Not yet recruiting
4
60
US
Buprenorphine/Naloxone, Suboxone
Massachusetts General Hospital
Post-operative Pain
12/22
12/22
PERFECT-AMI, NCT04731155: Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction

Recruiting
4
20
RoW
PCSK9 inhibitor (Alirocumab)plus standard medications, standard medications
Shanghai Tong Ren Hospital
Early PCSK9 Inhibitor on Ventricular Remodling
12/24
06/25
NCT05292404: Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction

Recruiting
4
160
RoW
alirocumab, conventional treatment
Shanghai Tong Ren Hospital, China Cardiovascular Association
Acute Myocardial Infarction
06/25
12/25
NCT05003245: Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD

Recruiting
3
388
RoW
HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection, Lucentis
Shanghai Henlius Biotech
Age Related Macular Degeneration
08/23
03/24
nAMD, NCT05461339: TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

Active, not recruiting
3
488
RoW
TAB014 Monoclonal Antibody Injection, TAB014, Ranibizumab Injection [Lucentis], Lucentis
TOT Biopharm Co., Ltd., Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Neovascular Age-related Macular Degeneration
09/24
02/25
 

Download Options